From: Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat
DENA Administration | Group | Histological diagnosis (no. animals) | ||||
---|---|---|---|---|---|---|
 |  | Healthy | Fibrosis stage | HCC | ||
 |  |  | F1-2 | F3 | F4 (cirrhosis) |  |
 | control | 3 |  |  |  |  |
week 0 | DENA | 2 | Â | Â | Â | Â |
 | control | 3 |  |  |  |  |
week 4 | DENA | Â | 6 | Â | Â | Â |
 | control | 3 |  |  |  |  |
week 6 | DENA | Â | 12 | Â | Â | Â |
 | control | 3 |  |  |  |  |
week 9 | DENA | Â | Â | 11 | 4 | Â |
 | control | 3 |  |  |  |  |
week 14 | DENA | Â | Â | Â | 5 | 2 |
 | control | 6 |  |  |  |  |
week 18 | DENA | Â | Â | Â | Â | 13 |